Institutional investors purchased a net $1.9 million shares of SGEN during the quarter ended December 2013 and now own 103.33% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 12.2 Thousand shares of Seattle Genetics Inc
AMUNDI SMITH BREEDEN LLC Bought 9.9 Thousand shares of Seattle Genetics Inc
DANSKE BANK A/S (INVESTMENT MANA... Bought 3.4 Thousand shares of Seattle Genetics Inc